Oregon Health Resources Commission

First Page		Document Content
Date: 2014-07-15 14:00:36 Asthma Leukotriene antagonists Combination drugs GlaxoSmithKline Formoterol Salmeterol Fluticasone/salmeterol Long-acting beta-adrenoceptor agonist Metered-dose inhaler Pulmonology Respiratory therapy Medicine		Oregon Health Resources Commission Add to Reading List Source URL: www.oregon.gov Download Document from Source Website File Size: 382,14 KB Share Document on Facebook

	Microsoft Word - Prosonix full abstract for DDL22_2_.doc DocID: 1rcKt - View Document
	COPD Care Map for Primary Care Patient Name: ______________________________________ DOB: ________________ Year of diagnosis:___________ Co-morbid conditions:______________________________________________________________ DocID: 1qO6l - View Document
	Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth DocID: 1oNoo - View Document
	European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using DocID: 1ooQZ - View Document
	PIPELINE WATCH Seretide SPCs reach the end of the road eptember brings the expiry of supplementary protection certificates (SPCs) for GlaxoSmithKline’s Seretide (fluticasone/salmeterol) blockbuster in several European DocID: 1mZXk - View Document